The relevance of the TLR2 signaling pathway in breast cancer is demonstrated by the fact that TLR2 expression has been found in human breast cancer samples, and that its expression is associated with poor overall survival and to resistance to endocrine therapy [64,65]. This evidence concerns the gene TLR2 and breast cancer.